| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Clinicopathological conference. A patient's life. | 1975 | Br Med J | pmid:1170920 | |
| Wiegratz I et al. | [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol]. | 2001 | Zentralbl Gynakol | pmid:11709743 |
| Harwood B and Mishell DR | Contraceptive vaginal rings. | 2001 | Semin. Reprod. Med. | pmid:11727180 |
| Haines CJ et al. | The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. | 2001 | Atherosclerosis | pmid:11730828 |
| Bruhat M et al. | Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study. | 2001 | Maturitas | pmid:11731187 |
| Herkert O et al. | Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. | 2001 | Circulation | pmid:11733402 |
| Weeke J and Hansen AP | Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives. | 1975 | Acta Endocrinol. | pmid:1173500 |
| Endrikat J et al. | Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations. | 2001 | Contraception | pmid:11747870 |
| Yamasaki K et al. | Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. | 2002 | Toxicology | pmid:11750080 |
| Mueck AO et al. | The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism. | 2001 | Horm. Metab. Res. | pmid:11753761 |
| Lópezde Alda MJ and Barceló D | Use of solid-phase extraction in various of its modalities for sample preparation in the determination of estrogens and progestogens in sediment and water. | 2001 | J Chromatogr A | pmid:11771833 |
| Nash HA and Sederholt D | Assessment of the toxicity of delivery systems for injectable contraceptives. | 1975 | J. Steroid Biochem. | pmid:1177434 |
| Morris SE and Cameron EH | Radioimmunoassay system for norethisterone using 3H- and 125I-labelled radioligands. | 1975 | J. Steroid Biochem. | pmid:1177442 |
| Warren RJ and Fotherby K | Iodine labelled ligands in the radioimmunoassay of synthetic progestins. | 1975 | J. Steroid Biochem. | pmid:1177443 |
| Zhang S et al. | [The efficacy and safety of domestic luteinizing hormone-releasing hormone analogue and low-dose norethindrone "add-back" therapy in the treatment of endometriosis]. | 2000 | Zhonghua Fu Chan Ke Za Zhi | pmid:11776204 |
| Beksinska ME et al. | Temporary discontinuation: a compliance issue in injectable users. | 2001 | Contraception | pmid:11777492 |
| pmid:11779584 | ||||
| Johnson JV et al. | Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. | 2002 Jan-Feb | Menopause | pmid:11791082 |
| Niskanen L et al. | Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? | 2002 Jan-Feb | Menopause | pmid:11791086 |
| Mueck AO et al. | [Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone]. | 2001 | Zentralbl Gynakol | pmid:11797164 |